BAT Korea Halves Prices of New Heated Tobacco Products

May.05.2023
BAT Korea Halves Prices of New Heated Tobacco Products
British American Tobacco (BAT) cuts prices by 50% for its new product in South Korea to increase pod sales, raising concerns over its long-term profitability.

Recently, according to a report from South Korean media outlet "Today's Economy," British American Tobacco (BAT) Korea has cut the price of their new heated but not burned product by half, within two months of its launch. The move is an attempt by BAT to boost sales of their pod product by offering lower prices. However, with decreasing profitability, the market is becoming increasingly skeptical about the long-term viability of this share-focused strategy.


Starting from April 17th, BAT is selling Glo Hyper X2 at a 50% discount off the original price. Although it is promoted as a sales campaign, it will continue until June 8th, which is essentially a price reduction.


Comparison of prices for non-burning products in the South Korean market | Graphic by 2FIRSTS.


BAT is increasing its market share through continuous promotional activities.


In 2021, the company offered a 90% discount on the price of the product Glo, selling it for 9,500 Korean won during a three-week pre-sale period. Subsequently, the company continued to sell the product at the same discounted rate throughout the year through several promotional events.


The "Glo Pro Slim" continued the promotional campaign when it was subsequently released.


KT&G and PMI Korea dominate the heated tobacco products market in South Korea with approximately 40% market share each. However, BAT's low pricing strategy has led to an increase in their market share. According to BAT, their market share has jumped from 6.04% in 2020 to 11.72% last year.


South Korean financial media outlet "Today's Finance" believes that the strategy of BAT is to generate actual revenue by introducing exclusive replacement pods. They initially used universal pods, but now have launched promotion-specific pods that are not compatible with other non-combustible heating products under their umbrella.


The idea is that the more users a product has, the greater its pod sales volume will be.


Dual Decline of Profits and Profit Margins


However, analysts have stated that this strategy is leading to a deterioration in the profitability of BAT.


Last year, South Korean BAT companies saw a 14.3% increase in revenue, reaching 539.8 billion Korean won, but operating profits decreased by 11.9% to 44.6 billion Korean won. Operating profit margins also declined from 10.7% to 8.3%. However, as the company did not disclose the performance of its South Korean subsidiary, Rothman's SpiceVibe, the specific amount of losses is still unclear.


The tobacco industry believes that the price threshold for low-end heated non-burning products is between 30,000 and 40,000 Korean won in order to maintain profit margins.


Once the selling price drops below this price, it means a loss in terms of cost.


An industry expert states:


This is a nascent market that only holds a 15% share of the entire tobacco market, hence a product expansion strategy may prove effective.


However, "BAT (Baidu, Alibaba, and Tencent) will find it difficult to continue bearing the losses generated by promotions and low-priced products.


Regarding this matter, a spokesperson for BAT stated, "We will focus on product sales in order to establish our position in the heated non-combustion market.


Related Reading:


PMI (Philip Morris International) teams up with KT&G (Korea Tobacco & Ginseng Corporation) to seize the global market, as BAT (British American Tobacco) aims to attract Korean customers through low pricing strategies.


KT&G and PMI compete for market leadership in South Korea.


The PMI profits of the South Korean market have increased by 163%, while BAT has experienced a decline of 12%.


ELFBAR, a South Korean agent, has reported an increase in initial orders and is aiming to sell 2 million units in South Korea this year.


South Korea may abandon the tax increase on HNB, which currently has a tax rate of 90.4% of regular cigarettes.


Reference/source:


Half-price just two months after release...How long will BAT's e-cigarette expansion strategy continue?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Japan Tobacco Inc. (JT) has introduced the Ploom AURA Glacier White heated tobacco device in Japan, adding a new color option to the existing Ploom AURA lineup. The device maintains the existing SMART HEATFLOW technology and HEAT SELECT SYSTEM with four heating modes, while expanding the ecosystem through new accessories including front panels, back covers, a car holder and wireless charging covers. The product entered pre-sale in Japan on June 30, 2026, followed by broader retail availability from July 7.
Aug.03
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives